Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
TOTAL PHARMA AS
AS
Active
Org 920250335
Bryggerikaien 24, 4014
Stavanger
Economic activity was not specified by tax authority
·
NACE 0000
Est. 2018 · 8 years old
0 employees
Overvåg
Share
Norway
/
Companies
/
Economic activity was not specified by tax authority
/
TOTAL PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−7
−6
−7
0
0
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−7
−6
−7
0
0
Net financials
0
0
0
0
0
Profit before tax
−7
−6
−7
0
0
Tax
−0
−0
−0
−0
−0
Net profit
−7
−6
−7
0
0
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
1
0
0
0
0
Equity
−9
−15
−22
−22
−22
Long-term debt
0
0
0
0
0
Short-term debt
10
15
22
22
22
Total debt
10
15
22
22
22
Financial ratios
5-year trend
EBITDA-margin
0.0%
This company
15.8%
Market median
-100% vs market
2021
2025
Soliditetsgrad
-2165100.0%
This company
38.2%
Market median
-5667901% vs market
2021
2025
Egenkapitalforrentning
0.0%
This company
18.4%
Market median
-100% vs market
2021
2025
Nettoresultatgrad
0.0%
This company
8.1%
Market median
-100% vs market
2021
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Gæld/egenkapital
1.00×
This company
0.62×
Market median
-61% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on TOTAL PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
